Cathie Wood's ARK ETFs have reported their daily trades for Monday, October 21, 2024, with a notable shuffle in their portfolio. The largest dollar-value trade came from the sale of 378,589 shares of Oklo Inc (NASDAQ:OKLO) through the ARKQ ETF, totaling approximately $6.9 million. This move suggests a significant shift in ARK's investment strategy regarding Oklo, as the fund has decided to reduce its position in the company.
On the buying side, ARK's ARKQ ETF acquired 31,271 shares of BWX Technologies Inc (NYSE:BWXT), with the transaction valued at nearly $3.95 million. This purchase was closely followed by an addition of 20,883 shares of Amazon.com Inc (NASDAQ:AMZN) to the ARKQ ETF, also amounting to approximately $3.95 million. These investments indicate ARK's continued confidence in the growth potential of both BWX Technologies and Amazon.
The daily trade report also highlighted ARK's ongoing interest in the healthcare sector with the purchase of 254,768 shares of Cerus Corp (NASDAQ:CERS) across the ARKK and ARKG ETFs, totaling about $433,105. This follows a trend from the previous week, where ARK consistently increased its stake in Cerus Corp, signaling a bullish outlook on the biomedical products company.
In addition, ARK continued to invest in the biotechnology space by buying 33,867 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) through both the ARKK and ARKG ETFs, with a total value of $1.66 million. This move adds to the series of recent purchases in CRISPR Therapeutics, underscoring ARK's strategy of accumulating shares in the gene-editing company.
Other acquisitions included 103,181 shares of 3D Systems Corp (NYSE:NYSE:DDD) through the ARKQ ETF, with a total dollar value of $315,733. The 3D printing company has seen sporadic interest from ARK over the past week, with varying levels of investment.
On the sell side, apart from the significant divestment in Oklo Inc, ARK made smaller sales, including 1,677 shares of Markforged Holding Corp (NYSE:MKFG) and 6,000 shares of Materialise NV (NASDAQ:MTLS), valued at $7,663 and $32,400 respectively. These sales represent minor adjustments to ARK's holdings in these companies.
Investors following Cathie Wood's ARK ETFs may interpret these trades as part of a broader strategy to optimize the portfolio for growth, with a focus on technology and healthcare sectors. The consistent investment in companies like Cerus Corp and CRISPR Therapeutics suggests a long-term vision for their respective industries, while the sale of Oklo Inc stock may indicate a reallocation of resources to more promising opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.